New insights into sexual dimorphism during progression of heart failure and rhythm disorders

Jérôme Thireau1, Franck Aimond, Denise Poisson

  • 1Centre National de la Recherche Scientifique FRE3092, Université François-Rabelais, F-37041 Tours, France.

Endocrinology
|February 24, 2010
PubMed

Insights

Female mice with heart failure (HF) show better protection against cardiac remodeling and rhythm disorders than males. This study highlights the role of sex hormones in HF progression and mortality, linking fibrosis and conduction time to outcomes.

Area of Science:

  • Cardiovascular Biology
  • Neuroendocrinology
  • Cardiac Electrophysiology

Background:

  • Neurohormonal imbalance significantly contributes to heart failure (HF) progression and mortality.
  • HF incidence and prevalence are notably lower in women compared to men.
  • Understanding sexual dimorphism in HF mechanisms is crucial for developing effective treatment strategies.

Purpose of the Study:

  • To investigate sexual dimorphism in the progression of neurohormonal-dependent heart failure using a mouse model.
  • To elucidate the role of sex hormones in cardiac remodeling, electrophysiological changes, and mortality in HF.
  • To explore the relationship between fibrosis, conduction abnormalities, and arrhythmias in male and female HF mice.

Main Methods:

  • Utilized a mouse model (TG4 strain) overexpressing the human beta2-adrenergic receptor to induce HF.
  • Assessed cardiac function via echocardiography and electrocardiography.
  • Performed histological studies, intracardiac electrophysiological exploration, and patch-clamp analysis.
  • Investigated hormonal influence through surgical gonadectomy.

Main Results:

  • TG4 mice exhibited high mortality, with a significant difference between males and females.
  • Male TG4 mice displayed intraventricular conduction abnormalities (prolonged infrahisian interval and QRS duration), increasing arrhythmia susceptibility.
  • HF severity correlated with fibrosis, which was modulated by gonadal hormones.
  • While cellular action potentials were similar, both sexes showed delayed repolarization compared to controls.

Conclusions:

  • Female TG4 mice demonstrated enhanced protection against cardiac remodeling and rhythm disorders compared to males.
  • A significant link was established between fibrosis, conduction time, and mortality, influenced by sex hormones.
  • These findings underscore the importance of sex-specific mechanisms in HF pathogenesis and suggest potential therapeutic targets.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...